Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.
暂无分享,去创建一个
F. Gaita | F. D’Ascenzo | G. Tarantini | U. Barbero | G. Biondi Zoccai | C. Moretti | P. Omede' | M. Reed | G. Frati | F. Colombo | James J. Di Nicolantonio | James J Di Nicolantonio